IP Library Granted Patent US 7,459,301
Granted Patent B2
US 7,459,301 · App. 11/281,186 · Granted Dec 2, 2008

Stereoisomerically enriched N-protected β-lactams using candida antarctica

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,459,301
App. No.
11/281,186
Granted
Dec 2, 2008
Kind
B2
Abstract

The present disclosure provides enzymatic methods for generating stereoisomerically pure products by resolving a racemic mixture of N-protected β-lactams with a lipase from Candida antarctica with high stereospecificity. The presence of a carbamate protecting group, such as the tert-butoxycarbonyl group protecting group, on the β-lactam enhances enzyme catalysis and stereoselectivity.

Claims (17)

1. A method for generating a stereoisomerically pure N-protected β-lactam from a mixture of diastereomers, comprising contacting an N-protected β-lactam mixture comprising enantiomers according to structural formulae (1) and (2):

wherein:

A represents a saturated or unsaturated, monocyclic, polycyclic or bridged polycyclic ring; and

R is a carbamate or thiocarbamate protecting group,

with a lipase from Candida antarctica under conditions in which the lipase selectively cleaves enantiomer 2, thereby yielding a mixture of reaction products according to structural formulae 1 and 4:

2. The method of claim 1 , wherein the carbamate protecting group is of the formula —C(O)OR 1 , where R 1 is selected from unsubstituted or substituted alkyl, unsubstituted or substituted (C6-C20) aryl and substituted or unsubstituted (C7-C26) arylalkyl.

3. The method of claim 2 , wherein R 1 is selected from t-butyl and benzyl.

4. The method of claim 1 , wherein A is selected from bicycloheptenyl, bicycloheptyl, cycloheptyl, cycloheptenyl, cyclohexyl, cyclohexenyl, cyclopentyl, cyclopentenyl, cyclopropyl, and cyclobutyl.

5. The method of claim 1 , wherein the lipase is a type B lipase.

6. The method of claim 1 , wherein the lipase is bound to a resin.

7. The method of claim 1 , wherein a catalytic amount of the lipase is used.

8. The method of claim 1 , wherein the contacting is carried out at a temperature in the range of about 0-80° C.

9. The method of claim 8 , wherein the temperature in the range of about 20-60° C.

10. The method of claim 1 , wherein the contacting is carried out in a solvent selected from diisopropyl ether, tetrahydrofuran, butanol, toluene, hexanes, acetonitrile, and mixtures thereof.

11. The method of claim 10 , wherein the solvent has a water content in the range about of 0.1 to 1.0 wt %.

12. The method of claim 1 , which further comprises the step of isolating compound 1 from compound 4.

13. The method of claim 12 , wherein the isolation is carried out by creating a base addition salt of compound 4 and removing said base addition salt via aqueous extraction of a mixture of an organic solution of compound 1 and said base addition salt.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2006
From: ARGADE, ANKUSH
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 017276/0306 →